Need help?

Biotechnology Businesses for Sale and Investment

Showing 1 - 14 of 36 Biotechnology Businesses for Sale and Investment. Buy or Invest in a Biotechnology, Agricultural Biotechnology, Biotech Facility, Biopharma, Bio Diagnostic, Bio Medical Device or a Bio Therapeutic Drug Business. Listed by Direct Business Owners & Business Brokers.
Filters
  • Biotechnology

 

Bio Therapeutic Drugs Company Investment Opportunity in Thiruvananthapuram, India

Kerala-based biotech company developing bioactive formulations, research services, and sustainable life science products.
Client base: Served a wide range of B2B and B2C clients, including corporates, institutions, and individual customers during the COVID-19 period through sanitizer supply. - Currently working with multiple researchers, organizations, and academic institutions for product formulation, outsourcing works, and collaborative projects. - Revenue model: Product sales – Revenue from biotech-based products (e. g. , sanitizers, organic formulations). Services – Income from outsourcing works, product formulation contracts, and collaborative R&D. Training & projects – Fees from student training programs and academic project guidance in biotechnology and life sciences. We get about INR 3-6 lakh of monthly revenue from the services mentioned above. - Promoter experience: The business is led by promoters with strong academic and professional backgrounds in biotechnology research, product development, and laboratory management, with proven expertise in collaborations and student mentorship. - Business relationships: Established strong collaborations with researchers, universities, and organizations for outsourcing projects, technology development, and training initiatives. - Business has a certificate of incorporation and GST certificate. - Awards & Recognition: Mockingjay Award. IVAEX Women’s Day Award. Recognized for contributions during COVID-19 through large-scale sanitizer supply. Appreciated by academic institutions for providing consistent training and project opportunities to students.
Kerala-based biotech company developing bioactive formulations, research services, and sustainable life science products.
7.5   Thiruvananthapuram
Run Rate Sales
USD 55 thousand
EBITDA Margin
10 %
Partial Stake Sale
USD 570 K for 25%
Contact Business

Bio Diagnostics Business for Sale in Amman, Jordan

Established bio-diagnostics manufacturing business for sale with FDA/CE-certified production and 63 staff.
Company: 25-year-old bio-diagnostics manufacturer based in Amman, Jordan, specializing in in vitro diagnostic reagents and medical lab reagent kits. - Workforce & scale: 63 employees operating US FDA- and CE-certified production and quality-control facilities. - Product line: Reagents and complete diagnostic kits used to measure analytes in human blood, urine, and stool for clinical chemistry and medical laboratories. - Production capacity: Able to produce 6,000 vials/day or ~1,000 kits/day, nominally ~24,000 kits/month at regular shifts; with overtime reaches ~30,000–35,000 kits/month. - Market coverage: Export-focused business selling to ~90 countries via dealer network; active dealers in 70+ countries across the USA, LATAM, Europe (strong in Germany and other EU markets), MENA (notably KSA), West Asia, Southeast Asia, Africa, and the Americas. - Customer profile: Primary customers are small-to-medium medical labs and diagnostic centers that consume 50–60% of the company’s routine reagent portfolio. Dealers/distributors serve larger regional purchasing and logistics. - Competitive strengths: Regulatory certifications (USFDA, CE), long industry track record, broad geographic distribution, and capacity to scale production to meet rising lab reagent demand. - Sales channels & monetization: Revenue generated through wholesale sales to dealers, direct bulk orders from clinical labs, and repeat sales of consumable reagents and diagnostic kits (recurring revenue from per-test consumables). - Monthly revenue depends on the number and size of orders, not on the number of employees.
Established bio-diagnostics manufacturing business for sale with FDA/CE-certified production and 63 staff.
8.3   Amman
Run Rate Sales
USD 4 million
EBITDA Margin
5 %
Business for Sale
USD 5 Mn
Contact Business

Biotechnology Business for Sale in Bengaluru, India

For sale: Microbiology, molecular-biology, and biotechnology contract research and testing laboratory, small-scale R&D production.
Located in Bangalore, this biotechnology and microbiology research and training organization specializes in training students and conducting small-scale research and development (R&D) production. - The organization provides hands-on training in biotechnology, microbiology, and DNA/RNA extraction, attracting students, PhD scholars, and startup companies. - Additionally, we offer essential food and water testing services to a diverse client base, including both regular and one-time customers. - With a robust presence in South India, the training institute boasts 20 years of experience and has recently expanded to include microbiology testing services initiated two years ago. - The laboratory collaborates with several small-scale industries throughout Bangalore, enhancing practical exposure for their trainees. - Each month, the institute educates between 20 to 30 students, contributing to the growth of skilled professionals in the biotechnology and microbiology fields. - Renowned for its quality service, the organization maintains a Google listing with a 4.4 rating and holds ISO, GST, and MSME certifications, affirming its commitment to industry standards.
For sale: Microbiology, molecular-biology, and biotechnology contract research and testing laboratory, small-scale R&D production.
7.4   Bengaluru
Run Rate Sales
USD 41 thousand
EBITDA Margin
40 %
Business for Sale
USD 63 K
Contact Business
List your business on SMERGERS.
Get visibility from 110,000+ member network of Businesses, Investors, Acquirers, Lenders and Advisors from 900+ Industries and 170+ Countries
Create Business Profile

Biotechnology Business for Sale in Bengaluru, India

For sale: Microbiology, molecular-biology, and biotechnology contract research and testing laboratory, small-scale R&D production.
Located in Bangalore, this biotechnology and microbiology research and training organization specializes in training students and conducting small-scale research and development (R&D) production. - The organization provides hands-on training in biotechnology, microbiology, and DNA/RNA extraction, attracting students, PhD scholars, and startup companies. - Additionally, we offer essential food and water testing services to a diverse client base, including both regular and one-time customers. - With a robust presence in South India, the training institute boasts 20 years of experience and has recently expanded to include microbiology testing services initiated two years ago. - The laboratory collaborates with several small-scale industries throughout Bangalore, enhancing practical exposure for their trainees. - Each month, the institute educates between 20 to 30 students, contributing to the growth of skilled professionals in the biotechnology and microbiology fields. - Renowned for its quality service, the organization maintains a Google listing with a 4.4 rating and holds ISO, GST, and MSME certifications, affirming its commitment to industry standards.
For sale: Microbiology, molecular-biology, and biotechnology contract research and testing laboratory, small-scale R&D production.
7.4   Bengaluru
Run Rate Sales
USD 41 thousand
EBITDA Margin
40 %
Business for Sale
USD 63 K
Contact Business

Newly Established Bio Diagnostics Company Investment Opportunity in Dubai, UAE

World’s absolute first instant methanol detection test protecting travelers and consumers from methanol poisoning.
Our brand is the world’s first instant methanol detection test, designed to protect consumers from deadly counterfeit alcohol. Our rapid-detection strip provides a fast, portable, and affordable solution for travelers, bars, hotels, and government agencies. HQ: Planned Dubai launch for cost-effective operations, global scalability, and safety of transactions. Market opportunity: $60B+ counterfeit alcohol crisis worldwide (1,000s of people die from methanol poisoning each year! and there is no way to test the drinks) Revenue model: • Direct-to-consumer (DTC): Sold online (Amazon, TikTok Shop, website) through major online retailers worldwide. • Bulk B2B sales: Hotels, universities, hospitals, pharmacies, retailers, train stations, bars, duty-free retailers. Globally. • Licensing deals: Partnering with biotech firms & alcohol brands for distribution. Projected price: ~$19.99 per pack, we must aim to have a 70% margin. Projected sales growth: •Year 1: 50K units → $1M revenue. •Year 2: 250K units → $5M revenue. •Year 3: 1M+ units → $20M+ revenue. Exit strategy: Sell to a biotech or alcohol safety giant etc for $50M+ or license the technology for passive royalties. Promoter experience & business relationships: • Founder: Experienced entrepreneur with expertise in luxury branding, viral marketing, and scaling consumer products with the globally recognized superstars behind the previous brand I have developed. • Scientific & business team: Partnering with chemists & biotech advisors to ensure product reliability. • Distribution talks: Engaging bars, airlines, hotels, etc. • Investor network: Seeking 1-2 strategic investors to fund final development and global launch. This product is positioned to disrupt a billion-dollar problem and scale as the go-to alcohol safety brand worldwide. Some of the brightest minds in biotech and science will be on board. The product is not medicine and does not need to be FDA-approved as we will market it as a consumer product (like pregnancy tests). The product will deliver a 90% accuracy which is enough to save millions of lives. This is a once-in-a-lifetime opportunity and we are applying for patents already.
7.1   Dubai
Run Rate Sales
Nil
EBITDA Margin
Nil
Partial Stake Sale
USD 1.17 Mn for 20%
Contact Business

Biotechnology Business Assets for Lease in Navi Mumbai, India

For lease: Fully equipped DCGI and USFDA approved 20,000 sq ft clinical research facility.
Clinical research facility for lease, spanning an expansive 20,000 sq ft, located in MIDC Industrial Area. - Fully equipped with advanced research infrastructure including 7 LCMS/MS and multiple deep freezers. - Facility includes more than 70 beds, catering to extensive clinical studies. - Approved by both DCGI and USFDA, ensuring compliance with top global standards. - In-house canteen available, enhancing convenience for long-term research projects. - Tenants have the flexibility to continue the existing business or repurpose the facility for different business ventures. - Property valued at approximately $2.3 million, excluding machinery and furnishings, providing significant value. - Open to infrastructure modifications to suit the lessee's requirements, ensuring versatile utility while maintaining core structure integrity. - The whole facility and the associated assets are completely owned by the business. - The promoter is US-based, but the rest of the directors and business operations are based in Navi Mumbai.
For lease: Fully equipped DCGI and USFDA approved 20,000 sq ft clinical research facility.
8.1   Navi Mumbai
Ownership Duration
10-20 year(s)
Industries
Biotechnology
Yearly Lease Amount
USD 300 K
Contact Business

Bio Diagnostics Company Investment Opportunity in Fremont, USA

Biotech company manufacturing high-quality assay kits for research in life sciences and healthcare, seeks investment.
Situated in Fremont, this business specializes in manufacturing assay kits for biochemicals, enzymes, and ions, serving primarily the life science and biotechnology sectors. - The company focuses on providing research products that are designed to be user-friendly, highly reproducible, and cost-effective, potentially advancing research in serious health conditions such as cancer, diabetes, and neurodegenerative diseases. - With a global network of 30-35 distributors, the company exports 90% of its products mainly to European and Asian markets, including key countries like China, Korea, and Japan. - The production capacity stands at manufacturing 500 kits per day, ensuring steady supply capabilities to meet the needs of international research communities. - Orders are fulfilled on a weekly basis, facilitating consistent supply and robust support for ongoing research projects worldwide. - The business is not yet profitable, as its revenue is being reinvested into expansion and growth efforts. - By focusing on quality and affordability, the company distinguishes itself as a competitive player in the assay kit market, supporting vital research across continents.
6.8   Fremont
Run Rate Sales
USD 50 thousand
EBITDA Margin
Nil
Partial Stake Sale
USD 50 K for 20%
Contact Business

Biotechnology Company Investment Opportunity in Tumkur, India

Global preclinical research company, over 300 clients served, seeks investment for tech upgrades and expansion.
Established as a premier Preclinical Contract Research Organisation, the company is GLP certified and ISO/IEC 17025:2017 accredited, ensuring high standards of quality. - Over the past decade, the company has successfully served over 300 clients, demonstrating a solid track record in the preclinical research sector with a focus on global markets. - Revenue generation is driven by conducting specialized studies on clients' products, showcasing the organisation's expertise and relevance in the current market. The profit margins are varying and constantly growing. - The firm boasts a diverse client base spread across the globe, highlighting its capability to meet international research demands and compliance standards. - The company holds prestigious AAALAC International and NABL certifications. - Promoted and led by a team of qualified professionals with robust experience in the industry. - Located in Tumkur, the organisation employs a skilled workforce of 120, combining local talent with global research best practices to deliver exceptional service.
Global preclinical research company, over 300 clients served, seeks investment for tech upgrades and expansion.
8   Tumkur
Run Rate Sales
USD 830 thousand
EBITDA Margin
Nil
Partial Stake Sale
USD 1.42 Mn for 5%
Contact Business

Newly Established Biotechnology Company Investment Opportunity in Haverhill, USA

Non-operational business offering CRO services and therapeutic protein distribution seeking funds to kick-start operations.
The company is strategically positioned in the biotechnology sector, with plans to specialize in high-demand services such as flow cytometry and cell culture, tailored to support pharmaceutical, biotech, and diagnostic companies. - Despite being registered 4 years ago, the company has yet to start operations but has laid the groundwork through strategic collaborations and grant submissions totalling approximately USD 40 million, showcasing a strong potential for funding acquisition. - The promoter's extensive background, with a PhD in cell biology and two decades of research experience, provides a strong foundation for the company's technical expertise and leadership. - Possession of distribution rights for crucial research kits and therapeutic proteins indicates early-stage readiness to supply essential products to the research community. - The company maintains strategic collaborations with antibody-based firms, enhancing its capability to provide comprehensive solutions for advanced therapeutic and research needs. - Haverhill, the company's location, provides access to a strategic geographical position that can facilitate partnerships with key biotech and pharmaceutical players. - The planned service offerings, including advanced flow cytometry and specialized cell culture services, underscore the company's commitment to supporting cutting-edge research with reliable and customizable solutions.
7.3   Haverhill
Run Rate Sales
Nil
EBITDA Margin
Nil
Partial Stake Sale
USD 1 Mn for 10%
Contact Business

Bio Medical Devices Company for Sale in Chennai, India

Established biomedical device business with expert team and educational partnerships for sale.
Established player in the biomedical devices sector, operating from Chennai with a focus on servicing bio-medical equipment and consultancy services. - Currently employs a dedicated team of 8 skilled professionals committed to excellence in service delivery. - Recognized as one of the top 25 companies with innovative products by the Wadhwani Foundation CEO, highlighting its commitment to quality and innovation. - Signed MOU with VIT University, Vellore, and IITM for internship training programs for students, fostering educational collaboration and real-world experience. - Successfully served over 550 hospitals, showcasing a strong market presence and customer trust. - Maintains strategic partnerships with Original Equipment Manufacturers (OEMs) to ensure seamless device procurement. - The promoter brings 33 years of industry experience, having held key positions in leading hospitals and multinational corporations, enhancing business credibility. - Registered with the Ministry of Corporate Affairs (MCA), ensuring compliance with legal frameworks within the industry.
6.6   Chennai
Run Rate Sales
USD 41 thousand
EBITDA Margin
40 %
Business for Sale
USD 1.7 Mn
Contact Business

Newly Established Bio Therapeutic Drugs Company Investment Opportunity in Udupi, India

Innovative Udupi-based translational medicinal drug products with gut health and gut microbiome innovation.
Industry overview: The business will operate in the nutraceutical sector, which is witnessing significant growth due to increasing health awareness and demand for nutritional supplements. - Strategic location: Based in Udupi, the company will be well-positioned to leverage local resources while also accessing global markets. - Innovative product offering: The company will specialise in the manufacturing of oral supplements aimed at treating various health complications and underlying disease conditions, catering to a diverse range of consumer needs. - Diverse client base: Potential clients include the National Health Service (NHS), pharmacies, health stores, and multinational corporations, allowing for both B2B and B2C sales strategies. - Experienced leadership: The promoter brings over 20 years of experience in the nutraceutical industry, providing a strong foundation for the company's growth and innovation. - Growth potential: With a focus on innovation and export, the company has the potential to evolve into a multibillion-dollar enterprise, tapping into the growing global demand for health supplements. - Regulatory compliance - the company is registered in the MCA and is yet to acquire the necessary licenses and approvals for manufacturing. - The promoter correctly resides in the UK.
6.8   Udupi
Run Rate Sales
Nil
EBITDA Margin
Nil
Partial Stake Sale
USD 284 K for 30%
Contact Business

Newly Established Bio Therapeutic Drugs Company Investment Opportunity in Monaragala, Sri Lanka

Ayurvedic doctor with 30+ years of experience needs a foreign investor for cannabis plantation.
Planning to establish a cannabis plantation to produce anesthetic drugs. - Seeking foreign investors to comply with the local law, which mandates that only foreigners can hold a license for cannabis plantations. - The promoter is an Ayurvedic doctor with 30 years of experience in the industry. - We will be applying for licenses, and only foreigners are eligible to hold them. - Our plan is to establish a cannabis plantation and export cannabis anesthetic drugs through distributors worldwide. - The drugs will be specifically formulated for anesthesia purposes.
6.2   Monaragala
Run Rate Sales
Nil
EBITDA Margin
Nil
Partial Stake Sale
USD 5 Mn for 40%
Contact Business

Profitable Biotechnology Company Investment Opportunity in Brussels, Belgium

Invest in a fully automated, end-to-end virtual screening platform, purpose-built for modern drug discovery.
A deep-tech company based in Flanders, Belgium, was established in February, 2 years ago. We specialize in delivering Artificial Intelligence (AI) and advanced Modeling & Simulation (M&S) solutions to the pharmaceutical industry, operating at the intersection of computational science and drug development. - Our core offerings include a proprietary Software-as-a-Service (SaaS) platform and specialized consulting services spanning the entire drug development lifecycle—from early discovery to late-stage development—including market access, pricing, and value demonstration for novel therapies. - We serve a diverse global client base across the pharmaceutical, biotechnology, and medical device sectors. - Our clientele includes key players such as Deloitte Belgium, UCB Pharma, Fresenius Kabi, B. Braun, and Translucency Ltd. - Through data-driven insights, we enable these partners to accelerate product development and optimize their market strategies. - The company has demonstrated consistent operational growth since its inception. Our revenues reflect this trajectory, with €76,000 reported two years ago, €118,062 last year, and a projected €164,200 for this fiscal year (ending in June). - The company maintains a stable financial position, underpinned by a net working capital of approximately €50,000, and has been awarded a €50,000 grant by VLAIO (Flanders Agency for Innovation and Entrepreneurship) to further develop our platform.
8.8   Brussels
Run Rate Sales
USD 192 thousand
EBITDA Margin
31 %
Partial Stake Sale
USD 290 K for 25%
Contact Business

Bio Therapeutic Drugs Company for Sale in Nea Anchialos, Greece

License for cultivation and distribution of Medical cannabis including plot and grant (840,000euros) for sale.
1. Greece's advantageous climate and geographic location make it an ideal setting for the development of a cannabis industry, leveraging abundant sunlight and easy access to European markets. 2. The company has received a substantial grant of EUR 840,000 from the development law, providing a financial boost with no repayment expectations. 3. Possessing a medical cannabis license enabling the production of up to 45 different products, the business has the potential to be among the top 10 distributors in Greece, positioning itself for significant market share. 4. The company holds licenses for cultivating and processing medicinal cannabis plants, focusing on the cultivation and processing of medicinal cannabis on a plot area of approximately 9,000 m2 in Nea Anchialos. 5. With the intention to achieve one of the highest levels of medical cannabis production in Europe over the next five years, the business has the potential to generate a gross profit of over 5 million euros. 6. The company has obtained the necessary legal documentation and licenses, including the first Installation approval license, to expedite the construction of a successful pharmaceutical cannabis facility, positioning it ahead of many others in the industry. 7. As a pioneer in Greece's medical cannabis sector, the business has the opportunity to capitalize on the location and the needs.
6.5   Nea Anchialos
Run Rate Sales
Nil
EBITDA Margin
Nil
Business for Sale
USD 210 K
Contact Business

Bio Diagnostics Company Investment Opportunity in Gurgaon, India

Med-tech R&D company with a patented technology for early stage multi-cancer detection seeks investors.
The company has pioneered the first blood-based cancer detection tests capable of identifying up to 30 common cancers. - We have consistently focused on innovative solutions for early-stage cancer detection to significantly reduce cancer-related deaths. - The company employs an ingenious approach that combines cutting-edge experimental tools with the latest advancements in deep learning methodologies. - With the global rise in cancer incidence, annual cancer deaths have also increased significantly. - Most cancers are diagnosed at late stages due to the absence of early clinical symptoms, leading to poor prognosis. - Early detection of cancer can reduce mortality by up to 70%, yet no current methods accurately detect cancer at early stages. - We have leveraged this opportunity by developing a groundbreaking blood test that detects 30 cancers in both males and females. - Our product integrates molecular mapping of the physiological state with a deep learning platform to identify cancer-specific molecular signatures. - The test is a novel, non-invasive blood-based screening method capable of detecting cancers and identifying the tissue of origin from the same sample. - The 30 cancers detected represent about 90% of new cancer cases each year. - Our test has achieved an unmatched accuracy of over 98% for early-stage cancer detection. - This advancement can significantly reduce the global cancer mortality burden. - The company is in the process of commercializing the test. - The promoter have over 40+ years of experience in the industry. - Licenses include CIN, SSM and GST. We have also applied for a USFDA. We have applied to the DCGI (Drugs Controller General of India) for market approval in India. We will launch operations post the DCGI approval. - Our target audience includes hospitals in India and Singapore. - Our R&D headquarters are in Haryana, with global headquarters in Singapore. - We also maintain an office in Singapore with dedicated staff.
Med-tech R&D company with a patented technology for early stage multi-cancer detection seeks investors.
8   Singapore
Run Rate Sales
Nil
EBITDA Margin
Nil
Partial Stake Sale
USD 14.2 Mn for 10%
Contact Business
Frequently
Asked
Questions
  • How many biotechnology businesses for sale and investment are listed on SMERGERS?
    There are 36 active and verified biotechnology businesses for sale and investment listed on SMERGERS as of 22 October 2025.
  • What level of due diligence does SMERGERS conduct on the businesses/member?

    SMERGERS scrutinizes all profiles and only features a select group of businesses, investors, advisors that meet a basic requirement. When required, certain members may have submitted some form of proof …read more

  • How active are the business profiles listed on SMERGERS?

    We regularly filter out businesses which are inactive or have already closed a transaction. Typically, if the business is actively looking to sell/raise capital, the status is shown in green.

  • How can I be sure about privacy and confidentiality?

    We understand the level of confidentiality required in strategic transactions and we strive to provide a safe and secure experience for our members. Please review our privacy policy. We …read more

  • How can I contact a business listed on SMERGERS?

    You need to be logged in before you connect with a business. Click here to register and message the business If you are already logged in, please use the contact …read more

  • Should you buy an existing business or start a business from scratch?

    Buying an existing business is generally an easier way to start a business with an immediate head start. It saves valuable time and administrative efforts, considering starting from scratch is …read more

  • How successful has SMERGERS been in helping its users successfully close a deal?

    SMERGERS is a discovery and matchmaking platform with a global reach. It helps in connecting Businesses, Investors, Acquirers, Lenders, M&A Advisors and Boutique Investment Banks across locations, industries and transactions. …read more

  • Show more